Results 151 to 160 of about 14,856,428 (286)
A practical approach to risk stratification of incidental T-cell clonality. [PDF]
Wilk AJ, Khodadoust M, Oak J.
europepmc +1 more source
Single‐center retrospective data showed that ATG‐based myeloablative haploidentical hematopoietic stem cell transplantation provides durable remission and favorable long‐term survival in children with refractory/relapsed non‐Hodgkin lymphoma, achieving high engraftment rates, low relapse incidence, and acceptable toxicity.
Chenguang Jia +12 more
wiley +1 more source
A 13-Year Review of Non-Diffuse Large B Cell Lymphomas of the Central Nervous System at a Tertiary Hospital: A Case Series Study. [PDF]
Sina N, Heyn C, Ghorab Z, Keith J.
europepmc +1 more source
Clinical Spectrum, Diagnostic Work-up, and Outcomes of Neurolymphomatosis in Lymphoid Malignancies: A 10-Patient Case Series. [PDF]
Alazzawi S +9 more
europepmc +1 more source
Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care
This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley +1 more source
Peripheral T-cell lymphoma: A developing concept
Pileri, S. A +3 more
openaire +2 more sources
Survival analysis and prognostic factors of mature T-cell and natural killer/T-cell neoplasms in Colombian patients from 2008-2025. [PDF]
Combariza-Vallejo JF +7 more
europepmc +1 more source
Multipathway schematic of endocrine therapy–induced cancer‐related fatigue. Endocrine interventions trigger four interacting mechanisms—neuroendocrine dysregulation, systemic inflammation, energy‐metabolic failure, and psycho‐behavioral amplification—that culminate in the multidimensional CRF phenotype.
Jiajing Jiang +7 more
wiley +1 more source
Antibody-drug conjugate development in lymphoma: a systematic clinical trial landscape analysis. [PDF]
Zhang H, Li J, Yan H, Liu Y.
europepmc +1 more source

